Concepedia

Robert Tullman

RT

Statistics

Publications

5

Citations

400

H-Index

5

Active since

1979

Affiliations

Novartis (Switzerland)(Current)

Robert Tullman is an author at Novartis (Switzerland) specializing in drug analysis, natural sciences, and medicine.

Top concepts

Publications per year

1979–2004

5

Publications

5

The 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Fluvastatin: Effect on Human Cytochrome P-450 and Implications for Metabolic Drug Interactions

Volker Fischer, Laurie Johanson, Francis Heitz et al. · Drug Metabolism and Disposition · 1999 · 148 citations

Suicidal inactivation of cytochrome P-450 by cyclopropylamines. Evidence for cation-radical intermediates

Robert P. Hanzlik, Robert Tullman · Journal of the American Chemical Society · 1982 · 120 citations

, , +23

Cyclopropylamines as suicide substrates for cytochromes P-450

Robert P. Hanzlik, Vimal Kishore, Robert Tullman · Journal of Medicinal Chemistry · 1979 · 47 citations

, , +16

Use of Classification Regression Tree in Predicting Oral Absorption in Humans

Jane P. F. Bai, Andrey Utis, Gordon M. Crippen et al. · Journal of Chemical Information and Computer Sciences · 2004 · 46 citations

Absorption and disposition of a tripeptoid and a tetrapeptide in the rat

Yanfeng Wang, Hanford Lin, Robert Tullman et al. · Biopharmaceutics & Drug Disposition · 1999 · 39 citations

, , +20

1–5 of 5